Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1984 Oct;52(1):293–297. doi: 10.1128/jvi.52.1.293-297.1984

Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes.

P M Keller, B J Neff, R W Ellis
PMCID: PMC254520  PMID: 6207311

Abstract

Varicella-zoster virus (VZV) codes for approximately eight glycosylated polypeptides in infected cell cultures and in virions. To determine the number of serologically distinct glycoprotein gene products encoded by VZV, we have developed murine monoclonal antibodies to purified virions. Of 10 monoclonal antibodies which can immunoprecipitate intracellular VZV antigens and virion glycoproteins, 1 (termed gA) reacted with gp105, 1 (termed gB) reacted with gp115 (intracellular only), gp62, and gp57, and 8 (termed gC) reacted with gp92, gp83, gp52, and gp45. The anti-gA monoclonal antibody neutralized VZV infectivity in the absence of complement. All eight anti-gC monoclonal antibodies neutralized only in the presence of complement. An anti-gB monoclonal antibody obtained from another laboratory also neutralizes in the absence of complement. Since the above reactivities account for all major detectable VZV glycoprotein species, the data strongly suggest that VZV has three major glycoprotein genes which encode glycosylated polypeptides with neutralization epitopes.

Full text

PDF
293

Images in this article

294Image
on p.294
295Image
on p.295
296Image
on p.296

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbeter A. M., Starr S. E., Weibel R. E., Neff B. J., Plotkin S. A. Live attenuated varicella vaccine: the KMcC strain in healthy children. Pediatrics. 1983 Mar;71(3):307–312. [PubMed] [Google Scholar]
  2. Arbeter A. M., Starr S. E., Weibel R. E., Plotkin S. A. Live attenuated varicella vaccine: immunization of healthy children with the OKA strain. J Pediatr. 1982 Jun;100(6):886–893. doi: 10.1016/s0022-3476(82)80506-4. [DOI] [PubMed] [Google Scholar]
  3. Asano Y., Albrecht P., Vujcic L. K., Quinnan G. V., Jr, Takahashi M. Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test. Arch Virol. 1983;75(3):225–228. doi: 10.1007/BF01315277. [DOI] [PubMed] [Google Scholar]
  4. Balachandran N., Harnish D., Killington R. A., Bacchetti S., Rawls W. E. Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2. J Virol. 1981 Aug;39(2):438–446. doi: 10.1128/jvi.39.2.438-446.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Braun D. K., Pereira L., Norrild B., Roizman B. Application of denatured, electrophoretically separated, and immobilized lysates of herpes simplex virus-infected cells for detection of monoclonal antibodies and for studies of the properties of viral proteins. J Virol. 1983 Apr;46(1):103–112. doi: 10.1128/jvi.46.1.103-112.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brunell P. A., Shehab Z., Geiser C., Waugh J. E. Administration of live varicella vaccine to children wtih leukaemia. Lancet. 1982 Nov 13;2(8307):1069–1073. doi: 10.1016/s0140-6736(82)90006-x. [DOI] [PubMed] [Google Scholar]
  7. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  8. Eberle R., Courtney R. J. Multimeric forms of herpes simplex virus type 2 glycoproteins. J Virol. 1982 Jan;41(1):348–351. doi: 10.1128/jvi.41.1.348-351.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Edson C. M., Thorley-Lawson D. A. Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus. J Virol. 1983 May;46(2):547–556. doi: 10.1128/jvi.46.2.547-556.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Forghani B., Schmidt N. J., Myoraku C. K., Gallo D. Serological reactivity of some monoclonal antibodies to varicella-zoster virus. Arch Virol. 1982;73(3-4):311–317. doi: 10.1007/BF01318084. [DOI] [PubMed] [Google Scholar]
  11. Gershon A. A., Raker R., Steinberg S., Topf-Olstein B., Drusin L. M. Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life. Pediatrics. 1976 Nov;58(5):692–696. [PubMed] [Google Scholar]
  12. Grose C., Edwards D. P., Friedrichs W. E., Weigle K. A., McGuire W. L. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun. 1983 Apr;40(1):381–388. doi: 10.1128/iai.40.1.381-388.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grose C., Friedrichs W. E., Smith G. C. Purification and molecular anatomy of the varicella-zoster virion. Biken J. 1983 Mar;26(1):1–15. [PubMed] [Google Scholar]
  14. Grose C. The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology. 1980 Feb;101(1):1–9. doi: 10.1016/0042-6822(80)90478-x. [DOI] [PubMed] [Google Scholar]
  15. Grose C. Zoster in children with cancer: radioimmune precipitation profiles of sera before and after illness. J Infect Dis. 1983 Jan;147(1):47–56. doi: 10.1093/infdis/147.1.47. [DOI] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. Neff B. J., Weibel R. E., Villarejos V. M., Buynak E. B., McLean A. A., Morton D. H., Wolanski B. S., Hilleman M. R. Clinical and laboratory studies of KMcC strain live attenuated varicella virus. Proc Soc Exp Biol Med. 1981 Mar;166(3):339–347. doi: 10.3181/00379727-166-41071. [DOI] [PubMed] [Google Scholar]
  19. Okuno T., Yamanishi K., Shiraki K., Takahashi M. Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens. Virology. 1983 Sep;129(2):357–368. doi: 10.1016/0042-6822(83)90175-7. [DOI] [PubMed] [Google Scholar]
  20. Pereira L., Dondero D., Norrild B., Roizman B. Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5202–5206. doi: 10.1073/pnas.78.8.5202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pereira L., Hoffman M., Gallo D., Cremer N. Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infect Immun. 1982 Jun;36(3):924–932. doi: 10.1128/iai.36.3.924-932.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pereira L., Klassen T., Baringer J. R. Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun. 1980 Aug;29(2):724–732. doi: 10.1128/iai.29.2.724-732.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Richert N. D., Davies P. J., Jay G., Pastan I. H. Characterization of an immune complex kinase in immunoprecipitates of avian sarcoma virus-transformed fibroblasts. J Virol. 1979 Sep;31(3):696–706. doi: 10.1128/jvi.31.3.696-706.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shemer Y., Leventon-Kriss S., Sarov I. Isolation and polypeptide characterization of varicella-zoster virus. Virology. 1980 Oct 15;106(1):133–140. doi: 10.1016/0042-6822(80)90228-7. [DOI] [PubMed] [Google Scholar]
  25. Shiraki K., Okuno T., Yamanishi K., Takahashi M. Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV). J Gen Virol. 1982 Aug;61(Pt 2):255–269. doi: 10.1099/0022-1317-61-2-255. [DOI] [PubMed] [Google Scholar]
  26. Showalter S. D., Zweig M., Hampar B. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infect Immun. 1981 Dec;34(3):684–692. doi: 10.1128/iai.34.3.684-692.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Strnad B. C., Schuster T., Klein R., Hopkins R. F., 3rd, Witmer T., Neubauer R. H., Rabin H. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. J Virol. 1982 Jan;41(1):258–264. doi: 10.1128/jvi.41.1.258-264.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Williams V., Gershon A., Brunell P. A. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis. 1974 Dec;130(6):669–672. doi: 10.1093/infdis/130.6.669. [DOI] [PubMed] [Google Scholar]
  29. Wolff M. H. The proteins of varicella-zoster-virus. Med Microbiol Immunol. 1978 Nov 17;166(1-4):21–28. doi: 10.1007/BF02121130. [DOI] [PubMed] [Google Scholar]
  30. Zweerink H. J., Neff B. J. Immune response after exposure to varicella zoster virus: characterization of virus-specific antibodies and their corresponding antigens. Infect Immun. 1981 Jan;31(1):436–444. doi: 10.1128/iai.31.1.436-444.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES